These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 2454642)

  • 21. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells.
    Clapham PR; Weber JN; Whitby D; McIntosh K; Dalgleish AG; Maddon PJ; Deen KC; Sweet RW; Weiss RA
    Nature; 1989 Jan; 337(6205):368-70. PubMed ID: 2536142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV infection of primate lymphocytes and conservation of the CD4 receptor.
    McClure MO; Sattentau QJ; Beverley PC; Hearn JP; Fitzgerald AK; Zuckerman AJ; Weiss RA
    Nature; 1987 Dec 3-9; 330(6147):487-9. PubMed ID: 2446142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
    Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
    Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes.
    Sattentau QJ; Arthos J; Deen K; Hanna N; Healey D; Beverley PC; Sweet R; Truneh A
    J Exp Med; 1989 Oct; 170(4):1319-34. PubMed ID: 2477490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limitations of the anti-idiotype strategy for an HIV vaccine.
    Beverley PC; Healey D; Broadhurst K; Sattentau QJ
    J Autoimmun; 1989 Jun; 2 Suppl():243-9. PubMed ID: 2789061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.
    Lasky LA; Nakamura G; Smith DH; Fennie C; Shimasaki C; Patzer E; Berman P; Gregory T; Capon DJ
    Cell; 1987 Sep; 50(6):975-85. PubMed ID: 2441877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of monoclonal antibodies that distinguish simian immunodeficiency virus isolates from each other and from human immunodeficiency virus types 1 and 2.
    Sutjipto S; Kodama T; Yee J; Gettie A; Jennings M; Desrosiers RC; Marx PA
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():247-9. PubMed ID: 1689369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody response.
    Zhang PF; Bouma P; Park EJ; Margolick JB; Robinson JE; Zolla-Pazner S; Flora MN; Quinnan GV
    J Virol; 2002 Jan; 76(2):644-55. PubMed ID: 11752155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120.
    DeVico AL; Rahman R; Welch J; Crowley R; Lusso P; Sarngadharan MG; Pal R
    Virology; 1995 Aug; 211(2):583-8. PubMed ID: 7544051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Productive infection of both CD4+ and CD4- human cell lines with HIV-1, HIV-2 and SIVagm.
    Werner A; Winskowsky G; Cichutek K; Norley SG; Kurth R
    AIDS; 1990 Jun; 4(6):537-44. PubMed ID: 1974766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.
    Gorny MK; Williams C; Volsky B; Revesz K; Cohen S; Polonis VR; Honnen WJ; Kayman SC; Krachmarov C; Pinter A; Zolla-Pazner S
    J Virol; 2002 Sep; 76(18):9035-45. PubMed ID: 12186887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus.
    Banapour B; Rosenthal K; Rabin L; Sharma V; Young L; Fernandez J; Engleman E; McGrath M; Reyes G; Lifson J
    J Immunol; 1987 Dec; 139(12):4027-33. PubMed ID: 2447158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation.
    Hildreth JE; Orentas RJ
    Science; 1989 Jun; 244(4908):1075-8. PubMed ID: 2543075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MHC-antigens: constituents of the envelopes of human and simian immunodeficiency viruses.
    Gelderblom H; Reupke H; Winkel T; Kunze R; Pauli G
    Z Naturforsch C J Biosci; 1987; 42(11-12):1328-34. PubMed ID: 2452527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques.
    Lehner T; Wang Y; Doyle C; Tao L; Bergmeier LA; Mitchell E; Bogers WM; Heeney J; Kelly CG
    Eur J Immunol; 1999 Aug; 29(8):2427-35. PubMed ID: 10458756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
    Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
    J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralisation of HIV isolates by anti-idiotypic antibodies which mimic the T4 (CD4) epitope: a potential AIDS vaccine.
    Dalgleish AG; Thomson BJ; Chanh TC; Malkovsky M; Kennedy RC
    Lancet; 1987 Nov; 2(8567):1047-50. PubMed ID: 2444842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-idiotypic antibodies against anti-CD4 antibodies MT151 and OKT4A.
    Liang SH; Rieber P; Prewett M; Riethmüller G; Pletcher C; Hoxie J; Koprowski H; Herlyn D
    Viral Immunol; 1991; 4(2):83-90. PubMed ID: 1722100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chemistry of site-directed serology for HIV infections.
    Norrby E; Biberfeld G; Johnson PR; Parks DE; Houghten RA; Lerner RA
    AIDS Res Hum Retroviruses; 1989 Oct; 5(5):487-93. PubMed ID: 2480152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.